Politics
Drugmakers Uninterested in Trump's MMR Split Order
Pharmaceutical companies and trade groups are unimpressed with President Trump’s executive order recommending the split of the MMR vaccine into three separate appointments, citing a lack of scientific basis.
Coverage timeline — 1 article
The Hill
President Trump's executive order recommending that the measles, mumps and rubella (MMR) vaccine be split up across three different appointments is drawing poor reception from the pharmaceutical industry as drugmakers and trade groups say there's no scientific reasoning to follow the directive. The
2026-08-17 17:00 UTC